论文信息 - LBA29Adjuvant GEMOX for biliary tract cancer: Updated relapse-free survival and first overall survival results of the randomized PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial - 字舞流文

LBA29Adjuvant GEMOX for biliary tract cancer: Updated relapse-free survival and first overall survival results of the randomized PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial

E. Assenat | A. Bertaut | F. Bonnetain | P. Hammel | J. Seitz | D. Malka | L. Fartoux | C. Louvet | J. Jouve | J. Phelip | J. Edeline | E. Boucher | R. Faroux | B. Juzyna | J. Joly | M. Benabdelghani | K. Bouhier‐Leporrier | V. Guérin-Meyer | J. Watelet | T. Stanbury